share_log

Despite Shrinking by US$343m in the Past Week, HealthEquity (NASDAQ:HQY) Shareholders Are Still up 40% Over 3 Years

Despite Shrinking by US$343m in the Past Week, HealthEquity (NASDAQ:HQY) Shareholders Are Still up 40% Over 3 Years

尽管在过去一周萎缩了3.43亿美元,但HealthEquity(纳斯达克股票代码:HQY)的股东在3年内仍上涨了40%
Simply Wall St ·  2023/10/26 13:11

By buying an index fund, investors can approximate the average market return. But many of us dare to dream of bigger returns, and build a portfolio ourselves. For example, HealthEquity, Inc. (NASDAQ:HQY) shareholders have seen the share price rise 40% over three years, well in excess of the market return (17%, not including dividends).

通过购买指数基金,投资者可以近似平均市场回报率。但是我们中的许多人敢于梦想获得更大的回报,并自己建立投资组合。例如, HealthEquity, Inc 纳斯达克股票代码:HQY)股东的股价在三年内上涨了40%,远远超过了市场回报(17%,不包括股息)。

Although HealthEquity has shed US$343m from its market cap this week, let's take a look at its longer term fundamental trends and see if they've driven returns.

尽管HealtheQuity本周市值已下跌3.43亿美元,但让我们来看看其长期基本面趋势,看看它们是否推动了回报。

Check out our latest analysis for HealthEquity

查看我们对HealthEquity的最新分析

While HealthEquity made a small profit, in the last year, we think that the market is probably more focussed on the top line growth at the moment. As a general rule, we think this kind of company is more comparable to loss-making stocks, since the actual profit is so low. For shareholders to have confidence a company will grow profits significantly, it must grow revenue.

尽管HealthEquity在去年获得了微薄的利润,但我们认为目前市场可能更关注收入增长。一般而言,我们认为这种公司更能与亏损股票相提并论,因为实际利润太低了。为了让股东有信心公司大幅增加利润,它必须增加收入。

HealthEquity's revenue trended up 8.4% each year over three years. That's pretty nice growth. The share price gain of 12% per year shows that the market is paying attention to this growth. Of course, valuation is quite sensitive to the rate of growth. Of course, it's always worth considering funding risks when a company isn't profitable.

HealthEquity的收入在三年内每年增长8.4%。这是相当不错的增长。股价每年上涨12%,表明市场正在关注这种增长。当然,估值对增长率非常敏感。当然,当公司无利可图时,始终值得考虑融资风险。

The company's revenue and earnings (over time) are depicted in the image below (click to see the exact numbers).

公司的收入和收益(随着时间的推移)如下图所示(点击查看确切数字)。

earnings-and-revenue-growth
NasdaqGS:HQY Earnings and Revenue Growth October 26th 2023
纳斯达克股票代码:HQY 收益和收入增长 2023 年 10 月 26 日

HealthEquity is well known by investors, and plenty of clever analysts have tried to predict the future profit levels. So it makes a lot of sense to check out what analysts think HealthEquity will earn in the future (free analyst consensus estimates)

HealthEquity为投资者所熟知,许多聪明的分析师都试图预测未来的利润水平。因此,看看分析师认为HealthEquity未来将获得多少收益很有意义(免费分析师共识估计)

A Different Perspective

不同的视角

HealthEquity shareholders are down 2.4% for the year, but the market itself is up 9.9%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Unfortunately, longer term shareholders are suffering worse, given the loss of 4% doled out over the last five years. We'd need to see some sustained improvements in the key metrics before we could muster much enthusiasm. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For instance, we've identified 1 warning sign for HealthEquity that you should be aware of.

HealthEquity的股东今年下跌了2.4%,但市场本身却上涨了9.9%。但是,请记住,即使是最好的股票有时也会在十二个月内表现逊于市场。不幸的是,鉴于过去五年中亏损了4%,长期股东遭受的损失更大。我们需要看到关键指标有所持续改善,然后才能激起人们的热情。尽管值得考虑市场状况可能对股价产生的不同影响,但还有其他因素更为重要。例如,我们已经确定了 HealthEquity 的 1 个警告信号 你应该知道的。

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of companies that have proven they can grow earnings.

如果你想去另一家公司看看 —— 一家财务状况可能优异的公司 —— 那千万不要错过这个 免费的 已证明可以增加收益的公司名单。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

请注意,本文引用的市场回报反映了目前在美国交易所交易的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?担心内容吗? 取得联系 直接和我们在一起。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St 的这篇文章本质上是笼统的。 我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。 它不构成买入或卖出任何股票的建议,也没有考虑您的目标或财务状况。我们的目标是为您提供由基本面数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。简而言之,华尔街在上述任何股票中都没有头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发